Blog
RSS FeedPosted by Michael Wonder on 02 Mar 2017
NICE recommends Ocaliva (obeticholic acid) for the treatment of patients with primary biliary cholangitis in England, Wales and Northern Ireland
2 March 2017 - Rapid NICE approval only two months after marketing authorisation in the EU; one of the fastest ...
Posted by Michael Wonder on 02 Mar 2017
Health funds’ hit list to save members $1.5bn a year
3 March 2017 - The private health insurance sector’s peak body has outlined measures in its pre-budget submission that it ...
Posted by Michael Wonder on 02 Mar 2017
NICE says patients accessing more cancer drugs following price drops
2 March 2017 - Patients will have routine access to more cancer drugs as companies have dropped their prices as part ...
Posted by Michael Wonder on 02 Mar 2017
Grant winners announced for new joint pharmaceuticals research fund
2 March 2017 - Researchers from Auckland and Otago Universities are the first recipients of new grants from PHARMAC and ...
Posted by Michael Wonder on 01 Mar 2017
'Give us the chance to live': mum suffering from breast cancer begs for life-extending drug Kadcyla to be available on NHS
1 March 2017 - Lesley Stephen watched her friend Annie die of cancer after being refused the drug and decided to ...
Posted by Michael Wonder on 01 Mar 2017
Palbociclib in advanced breast cancer: disadvantages in certain patients
1 March 2017 - More frequent severe side effects in first-line therapy after menopause/missing data for other patients. ...
Posted by Michael Wonder on 28 Feb 2017
Pharma company gives up on PHARMAC–gives drug free to New Zealand patients
28 February 2017 - Sanofi Genzyme developed Myozyme, a complex biological treatment for Pompe disease, a lysosomal disease, over ten ...
Posted by Michael Wonder on 28 Feb 2017
Pathology providers guarantee to continue to provide Pap Tests for Australian women
28 February 2017 - The Federal Department of Health has reached agreement with representatives of the Australian Pathology providers which will ...
Posted by Michael Wonder on 28 Feb 2017
Universal public coverage of essential drugs would improve health care, research suggests
27 February 2017 - Price of medication for high blood pressure, diabetes sometimes blocks patients' treatment. ...
Posted by Michael Wonder on 28 Feb 2017
NICE publishes draft guidance on Keytruda
28 February 2017 - The Department of Health has asked NICE to produce guidance on using pembrolizumab in the NHS in ...
Posted by Michael Wonder on 28 Feb 2017
PBS website update - 1 March 2017
1 March 2017 - The Schedule of Pharmaceutical Benefits for February 2017 will remain effective until the April 2017 Schedule ...
Posted by Michael Wonder on 28 Feb 2017
New Zealand Pharmaceutical Schedule - 1 March 2017
1 March 2017 - The March 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Feb 2017
Forget the banks – health insurance makes them look like amateurs
27 February 2017 - More Australian than hot summers and bagging cricket selectors is the habit of criticising the Big ...
Posted by Michael Wonder on 27 Feb 2017
Additional listings on the Pharmaceutical Schedule of a range of orthopaedic implants and associated products with Smith and Nephew Limited
27 February 2017 - PHARMAC is pleased to announce the approval of an amendment to the trauma agreement with Smith ...
Posted by Michael Wonder on 26 Feb 2017
All high earners to pay Medicare levy surcharge under budget proposal
27 February 2017 - All high-income Australians would pay the 1 to 1.5 per cent Medicare levy surcharge under a ...